GlaxoSmithKline Reveals Ingenuity In a further validation of Big Pharma�s acceptance of systems biology, GlaxoSmithKline has licensed part of the Ingenuity Pathways Knowledge Base to facilitate genome-wide computational analysis of biological systems underlying disease.
The Best in Drugs and Biotech: “S&P’s Herman Saftlas and Frank DiLorenzo share some favorites in these resurgent sectors, including Barr Pharmaceuticals and MedImmune “
What VCs Don’t Tell You: “To secure funding, an entrepreneur needs to appreciate the goals and strategies at work on the other side the table. Here’s a guide “
Building a Better R&D Mousetrap: “By posting their scientific conundrums online, companies like Eli Lilly and Procter & Gamble have discovered a rich new source of brainpower.”
A WTO deal on drugs India and Brazil are good at making cheap copies of life-saving drugs. Now they are allowed to export them too…
Biotechs big winners in VC rebound Biotechnology companies are leading a rebound in venture capital investment in the New York metro area, a new survey shows. Investors put $380 million into 56 companies in the second quarter of this year, for a 63% jump in venture capital investment over the first quarter, according to the […]
Vatican in favour of GM Food : “The Vatican has made an endorsement of controversial genetically modified foods by declaring that they hold the answer to world starvation and malnutrition.”
Genetically engineered trees sprouting quietly… for now Roll over John Muir and tell Johnny Appleseed the news: biotechnology is coming to the forest and orchard.
Antibiotics, The Next Generation Few things are as inexorable as the march of bacterial resistance. When a person or animal is given an antibiotic, it kills enough pathogens to cure the illness. But bacteria that have mutated so they can resist the drug survive. The next time these bacteria cause an infection, the antibiotic is […]
The War against ‘Viagra’ The US Food and Drug Administration has announced plans to fight counterfeit drugs. The FDA will introduce technology that could show at a glance if drugs are real, such as watermarks or electronic tags. It will also tighten requirements for drug wholesalers so it’s tougher to sneak counterfeits into legitimate supplies.